key: cord-0052815-0degldbz
authors: Chang, Jiwoon; Swenson, Kai E.; Sung, Arthur; Bedi, Harmeet
title: COVID-19 Test Correlation Between Nasopharyngeal Swab and Bronchoalveolar Lavage in Asymptomatic Patients
date: 2020-11-17
journal: Chest
DOI: 10.1016/j.chest.2020.11.006
sha: a327968e6f1e57b289eeeeb60030e8bb2287c23d
doc_id: 52815
cord_uid: 0degldbz

nan

The American College of Chest Physicians (CHEST) and the American Association of Bronchology and Interventional Pulmonology (AABIP) recommend testing for the coronavirus disease 2019 (COVID-19) prior to performing bronchoscopy in asymptomatic patients where COVID-19 is present in the community 1 . While the rate and availability of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) testing have improved since COVID-19 was first detected in the US, the reliability and interpretation of test results have been questioned, due to variable rates of community spread, varying test characteristics depending on site and technique, and the lack of a gold standard test. Specifically, discrepancies have been reported between nasopharyngeal (NP) and bronchoalveolar lavage (BAL) SARS-CoV-2 positivity, with multiple case reports describing such false-negative NP swabs among symptomatic patients who are eventually diagnosed with COVID-19 2-4 . The data is even more scant for such potential discrepancies among asymptomatic or presymptomatic patients, who appear to be responsible for a considerable amount of transmission especially in close-quarters, high risk environments 5 .

To our knowledge, no study has yet evaluated test concordance between NP swab and BAL among asymptomatic patients living in a community with COVID-19 transmission. In this study, we report the positive and negative rates of SARS-CoV-2 RT-PCR results from NP swabs and BAL and their correlations among asymptomatic patients undergoing bronchoscopy.

The study was conducted at Stanford University Medical Center (Stanford, California) between April 13 th 2020 and July 10 th 2020. Our institution began NP swab testing of all asymptomatic J o u r n a l P r e -p r o o f patients prior to surgeries and procedures on April 6, 2020. All patients undergoing bronchoscopy, including inpatient and outpatient, were included.

All patients underwent NP swab SARS-CoV-2 RT-PCR for screening prior to scheduled bronchoscopy; for outpatient procedures, the NP swab was performed within 72 hours of the procedure and was required to be negative. For inpatient bronchoscopy, a negative NP swab was Review Board (Protocol #56060) and individual consent was not required.

A total of 206 bronchoscopies were performed in 177 eligible patients. 18 patients underwent 2 or more bronchoscopies during the study period. All patients underwent screening NP swab prior to the procedure and BAL during bronchoscopy. There was one positive NP swab in an J o u r n a l P r e -p r o o f asymptomatic patient whose outpatient bronchoscopy was therefore delayed. Among 206 cases which NP swabs were negative and therefore proceeded to bronchoscopy, all BAL SARS-CoV-2 RT-PCR tests were negative, demonstrating 100% concordance between NP and BAL samples.

Demographic and clinical data are summarized in Table 1 and Table 2 

In this prospective study, we found no discordance between negative initial nasopharyngeal tests and bronchoscopic BAL tests for SARS-CoV2 by RT-PCR in 206 consecutive bronchoscopies.

These findings suggest that SARS-CoV-2 RT-PCR from NP swabs is an effective screening technique when compared to BAL and supports their use as the standard screening tests for patients with low clinical suspicion for COVID-19 who are undergoing bronchoscopy. Wang et al described SARS-CoV-2 detection rate from various biospecimens in 205 patients with COVID-19 and found BAL samples with a positive rate of 93%, nasal swabs with 63%, and pharyngeal swabs with 32% 6 . However, their patient population only included patients with symptomatic COVID-19 disease, whereas our population was specifically screened to be J o u r n a l P r e -p r o o f negative for COVID-19. Thus, their report of discrepancies between NP and BAL testing is not contrary to our finding of significant concordance between paired samples of negative NP and BAL tests.

Limitations of our study include the difficulty of determining test characteristics of nasopharyngeal COVID-19 testing in our patient population, in combination with the local incidence and prevalence among the patient population being tested. Furthermore, a study performed at our institution of testing in both asymptomatic and symptomatic patients found an estimated false negative rate of 3.5% among initial NP swab testing if the test was repeated in 1 week 7 . While all NP swabs were collected by trained health-care workers, negative tests could have been due to inadequate specimen collection, handling, or processing 8 .

In conclusion, we found that all patients with low clinical suspicion for COVID-19 that tested negative for SARS-CoV-2 RT-PCR from NP swabs also tested negative for COVID-19 from BAL samples, with no test discrepancy between screening NP swabs and BAL. This finding supports the use of NP swab test as an appropriate screening test for aerosol-generating procedures in the midst of the current pandemic.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f

The Use of Bronchoscopy During the Coronavirus Disease

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report

Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19

Radiologypathology Correlation in Recovered COVID-19, Demonstrating Organizing Pneumonia

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus

Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients. Clinical Infectious Diseases

Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)

SARS-CoV-2: severe acute respiratory syndrome coronavirus-2 NP: nasopharyngeal BAL: bronchoalveolar lavage CHEST: American College of Chest Physicians AABIP: American Association of Bronchology and Interventional Pulmonology